Smaller total and subregional cerebellar volumes in posttraumatic stress disorder: a mega-analysis by the ENIGMA-PGC PTSD workgroup
- PMID: 38195980
- PMCID: PMC11153161
- DOI: 10.1038/s41380-023-02352-0
Smaller total and subregional cerebellar volumes in posttraumatic stress disorder: a mega-analysis by the ENIGMA-PGC PTSD workgroup
Abstract
Although the cerebellum contributes to higher-order cognitive and emotional functions relevant to posttraumatic stress disorder (PTSD), prior research on cerebellar volume in PTSD is scant, particularly when considering subregions that differentially map on to motor, cognitive, and affective functions. In a sample of 4215 adults (PTSD n = 1642; Control n = 2573) across 40 sites from the ENIGMA-PGC PTSD working group, we employed a new state-of-the-art deep-learning based approach for automatic cerebellar parcellation to obtain volumetric estimates for the total cerebellum and 28 subregions. Linear mixed effects models controlling for age, gender, intracranial volume, and site were used to compare cerebellum volumes in PTSD compared to healthy controls (88% trauma-exposed). PTSD was associated with significant grey and white matter reductions of the cerebellum. Compared to controls, people with PTSD demonstrated smaller total cerebellum volume, as well as reduced volume in subregions primarily within the posterior lobe (lobule VIIB, crus II), vermis (VI, VIII), flocculonodular lobe (lobule X), and corpus medullare (all p-FDR < 0.05). Effects of PTSD on volume were consistent, and generally more robust, when examining symptom severity rather than diagnostic status. These findings implicate regionally specific cerebellar volumetric differences in the pathophysiology of PTSD. The cerebellum appears to play an important role in higher-order cognitive and emotional processes, far beyond its historical association with vestibulomotor function. Further examination of the cerebellum in trauma-related psychopathology will help to clarify how cerebellar structure and function may disrupt cognitive and affective processes at the center of translational models for PTSD.
© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
NJ received partial research support from Biogen, Inc. (Boston, USA) for research unrelated to the content of this manuscript. PMT received partial research support from Biogen, Inc. (Boston, USA) for research unrelated to the topic of this manuscript. CS is consultant for Boehringer Ingelheim International GmbH. LAML reports unpaid membership on the Scientific Committee for the International Society for the Study of Trauma and Dissociation (ISSTD), grant support from the National Institute of Mental Health, K01 MH118467, and spousal IP payments from Vanderbilt University for technology licensed to Acadia Pharmaceuticals unrelated to the present work. ISSTD and NIMH were not involved in the analysis or preparation of the manuscript. WEH is affiliated with Air Liquide, Boehringer Ingelheim, CHUGAI, EISAI, Jazz Pharmaceuticals, Janssen, Lundbeck, Novartis, Otsuka, UCB but nothing related to this work. RJD is the founder and president of, and serves on the board of directors for, the non-profit organization Healthy Minds Innovations, Inc. CGA has served as a consultant, speaker and/or on advisory boards for FSV7, Lundbeck, Psilocybin Labs, Genentech, Janssen and Aptinyx; served as editor of Chronic Stress for Sage Publications, Inc; and filed a patent for using mTOR inhibitors to augment the effects of antidepressants (filed on August 20, 2018). JHK is a consultant for AbbVie, Inc., Amgen, Astellas Pharma Global Development, Inc., AstraZeneca Pharmaceuticals, Biomedisyn Corporation, Bristol-Myers Squibb, Eli Lilly and Company, Euthymics Bioscience, Inc., Neurovance, Inc., FORUM Pharmaceuticals, Janssen Research & Development, Lundbeck Research USA, Novartis Pharma AG, Otsuka America Pharmaceutical, Inc., Sage Therapeutics, Inc., Sunovion Pharmaceuticals, Inc., and Takeda Industries; is on the Scientific Advisory Board for Lohocla Research Corporation, Mnemosyne Pharmaceuticals, Inc., Naurex, Inc., and Pfizer; is a stockholder in Biohaven Pharmaceuticals; holds stock options in Mnemosyne Pharmaceuticals, Inc.; holds patents for Dopamine and Noradrenergic Reuptake Inhibitors in Treatment of Schizophrenia, US Patent No. 5,447,948 (issued September 5, 1995), and Glutamate Modulating Agents in the Treatment of Mental Disorders, U.S. Patent No. 8,778,979 (issued July 15, 2014); and filed a patent for Intranasal Administration of Ketamine to Treat Depression. U.S. Application No. 14/197,767 (filed on March 5, 2014); US application or Patent Cooperation Treaty international application No. 14/306,382 (filed on June 17, 2014). Filed a patent for using mTOR inhibitors to augment the effects of antidepressants (filed on August 20, 2018). A version of this manuscript was uploaded to the biorxiv.org preprint server (10.1101/2022.10.13.512111).
Figures
References
-
- Association AP. Diagnostic and statistical manual of mental disorders(5th ed), 2013.
-
- Harnett NG, Goodman AM, Knight DC. PTSD-related neuroimaging abnormalities in brain function, structure, and biochemistry. Exp Neurol. 2020;330:113331. - PubMed
-
- Karl A, Schaefer M, Malta LS, Dorfel D, Rohleder N, Werner A. A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev. 2006;30:1004–31. - PubMed
Publication types
MeSH terms
Grants and funding
- I01 RX002171/RX/RRD VA/United States
- R21MH106998/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- I01 RX002170/RX/RRD VA/United States
- 27040/Brain and Behavior Research Foundation (Brain & Behavior Research Foundation)
- R01 MH129832/MH/NIMH NIH HHS/United States
- R01MH105535/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- I01 RX002172/RX/RRD VA/United States
- P41 EB015922/EB/NIBIB NIH HHS/United States
- P50/U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- I01 RX002174/RX/RRD VA/United States
- W81XWH-10-1-0925/U.S. Department of Defense (United States Department of Defense)
- R56 MH071537/MH/NIMH NIH HHS/United States
- 20ZDA079/National Natural Science Foundation of China (National Science Foundation of China)
- P30 HD003352/HD/NICHD NIH HHS/United States
- R01AG059874/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
- R01MH107382/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- R61NS120249/U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- K01 MH122774/MH/NIMH NIH HHS/United States
- I01 RX003444/RX/RRD VA/United States
- IK2 RX002922/RX/RRD VA/United States
- R01AG022381/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
- 31971020/National Natural Science Foundation of China (National Science Foundation of China)
- R21 MH098212/MH/NIMH NIH HHS/United States
- R01 MH113574/MH/NIMH NIH HHS/United States
- K12 HD085850/HD/NICHD NIH HHS/United States
- 1IK2CX001680/U.S. Department of Veterans Affairs (Department of Veterans Affairs)
- R01 MH071537/MH/NIMH NIH HHS/United States
- HD085850/U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- R21 MH106998/MH/NIMH NIH HHS/United States
- I01 RX003442/RX/RRD VA/United States
- IK2 CX001680/CX/CSRD VA/United States
- 14848/Michael J. Fox Foundation for Parkinson's Research (Michael J. Fox Foundation)
- R01 AG064955/AG/NIA NIH HHS/United States
- R01MH110483/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- I01 CX001135/CX/CSRD VA/United States
- 1IK2RX000709/U.S. Department of Veterans Affairs (Department of Veterans Affairs)
- R21 MH112956/MH/NIMH NIH HHS/United States
- W81XWH-08-2-0038/United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (CDMRP)
- R01 MH105355/MH/NIMH NIH HHS/United States
- K23MH090366/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- K01 MH118428/MH/NIMH NIH HHS/United States
- R01 MH105535/MH/NIMH NIH HHS/United States
- MH101380/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- WA 1539/8-2/Deutsche Forschungsgemeinschaft (German Research Foundation)
- M01RR00039/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- M01 RR000039/RR/NCRR NIH HHS/United States
- I01 RX003443/RX/RRD VA/United States
- R01 MH111671/MH/NIMH NIH HHS/United States
- R01 MH106574/MH/NIMH NIH HHS/United States
- R01 MH116147/MH/NIMH NIH HHS/United States
- R01MH111671/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- R01MH117601/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- 1K2RX002922/U.S. Department of Veterans Affairs (Department of Veterans Affairs)
- I01 RX001880/RX/RRD VA/United States
- R21MH102634/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- MH071537/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- I01 RX000622/RX/RRD VA/United States
- R01MH096987/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- K01MH122774/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- I01 HX003155/HX/HSRD VA/United States
- R01MH106574/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- U54 EB020403/EB/NIBIB NIH HHS/United States
- R01 MH117601/MH/NIMH NIH HHS/United States
- I01 RX001774/RX/RRD VA/United States
- I01 CX002097/CX/CSRD VA/United States
- UL1TR000454/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- I01 RX002076/RX/RRD VA/United States
- R01 MH119227/MH/NIMH NIH HHS/United States
- K01MH118467/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- SFB/TRR 58: C06, C07/Deutsche Forschungsgemeinschaft (German Research Foundation)
- U21A20364/National Natural Science Foundation of China (National Science Foundation of China)
- BK20221554/Natural Science Foundation of Jiangsu Province (Jiangsu Provincial Natural Science Foundation)
- UL1 TR000454/TR/NCATS NIH HHS/United States
- R01 MH107382/MH/NIMH NIH HHS/United States
- R01MH119227/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- I01 CX001246/CX/CSRD VA/United States
- MH098212/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- R56 AG058854/AG/NIA NIH HHS/United States
- 40-00812-98-10041/ZonMw (Netherlands Organisation for Health Research and Development)
- T32 MH018931/MH/NIMH NIH HHS/United States
- R01 AG076838/AG/NIA NIH HHS/United States
- K23 MH101380/MH/NIMH NIH HHS/United States
- R01 MH043454/MH/NIMH NIH HHS/United States
- R21 MH102634/MH/NIMH NIH HHS/United States
- K01MH118428/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- HD071982/U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- R01 HD071982/HD/NICHD NIH HHS/United States
- K23 MH090366/MH/NIMH NIH HHS/United States
- I01 RX002173/RX/RRD VA/United States
- R01MH105355/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- I01RX000622/U.S. Department of Veterans Affairs (Department of Veterans Affairs)
- W81XWH-12-2-0012/U.S. Department of Defense (United States Department of Defense)
- R61 NS120249/NS/NINDS NIH HHS/United States
- R21MH098198/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- K01 MH118467/MH/NIMH NIH HHS/United States
- I01 CX002096/CX/CSRD VA/United States
- I01 CX001820/CX/CSRD VA/United States
- R21MH112956/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- IK2 RX000709/RX/RRD VA/United States
- I01 RX001135/RX/RRD VA/United States
- DA 1222/4-1/Deutsche Forschungsgemeinschaft (German Research Foundation)
- R01 MH096987/MH/NIMH NIH HHS/United States
- 1184403/Department of Health | National Health and Medical Research Council (NHMRC)
- R01 AG022381/AG/NIA NIH HHS/United States
- R01 AG050595/AG/NIA NIH HHS/United States
- M01RR00039/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- R01AG050595/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
- R01 AG059874/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
